把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注，缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存；每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR，A 股链接巨潮原始 PDF，港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性，不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查；超出容差的记录保留原值并标记警告， 不会为了让公式“对上”而修改公司披露。
| 2026-06-30 |
| 3/3 |
| $3.16B |
| -$1.44B |
| -$44.9M |
| 32.8% |
| -66.3% |
| 86 |
| 尚无授权文本 |
| BCYC BICYCLE THERAPEUTICS PLC | 2026-06-30 | 3/3 | $629,000 | -$50.33M | -$116.51M | — | -8673.9% | 102 | 尚无授权文本 |
| BHC Bausch Health Companies Inc. | 2026-06-30 | 3/3 | $2.85B | $258M | $714M | — | 25.9% | 134 | 尚无授权文本 |
| BHE BENCHMARK ELECTRONICS INC | 2026-06-30 | 3/3 | $777.5M | $19.88M | $52.92M | 10.1% | 3.9% | 104 | 尚无授权文本 |
| BKR Baker Hughes Co | 2026-06-30 | 3/3 | $6.74B | $681M | — | — | — | 97 | 尚无授权文本 |
| CORT CORCEPT THERAPEUTICS INC | 2026-06-30 | 3/3 | $256.15M | $42.99M | $14.04M | 98.4% | 16.1% | 85 | 尚无授权文本 |
| CTNM Contineum Therapeutics, Inc. | 2026-06-30 | 3/3 | — | -$15.15M | -$28.09M | — | — | 35 | 尚无授权文本 |
| CYH COMMUNITY HEALTH SYSTEMS INC | 2026-06-30 | 3/3 | $2.83B | $70M | -$361M | 85.8% | 13.8% | 137 | 尚无授权文本 |
| DYN Dyne Therapeutics, Inc. | 2026-06-30 | 3/3 | — | -$178.56M | -$276.94M | — | — | 88 | 尚无授权文本 |
| ELV Elevance Health, Inc. | 2026-06-30 | 3/3 | $50.47B | $1.46B | $5.72B | 89.1% | 3.5% | 91 | 尚无授权文本 |
| FULC Fulcrum Therapeutics, Inc. | 2026-06-30 | 3/3 | — | -$26.18M | -$34.91M | — | — | 94 | 尚无授权文本 |
| GH Guardant Health, Inc. | 2026-06-30 | 3/3 | $334.98M | -$120.14M | -$140.74M | 65.4% | -38.5% | 102 | 尚无授权文本 |
| GSHD Goosehead Insurance, Inc. | 2026-06-30 | 3/3 | $113.39M | $10.07M | $35.67M | — | 23.5% | 70 | 尚无授权文本 |
| HCSG HEALTHCARE SERVICES GROUP INC | 2026-06-30 | 3/3 | $470.81M | $22.7M | $62.57M | 15.9% | — | 65 | 尚无授权文本 |
| HCXY Hercules Capital, Inc. | 2026-06-30 | 3/3 | — | $130.18M | — | — | — | 96 | 尚无授权文本 |
| HR Healthcare Realty Trust Inc | 2026-06-30 | 3/3 | $8.03M | -$43.51M | — | — | — | 124 | 尚无授权文本 |
| HRI HERC HOLDINGS INC | 2026-06-30 | 3/3 | $204M | $19M | $509M | — | — | 87 | 尚无授权文本 |
| HTGC Hercules Capital, Inc. | 2026-06-30 | 3/3 | — | $130.18M | — | — | — | 96 | 尚无授权文本 |
| HXL HEXCEL CORP /DE/ | 2026-06-30 | 3/3 | $529.3M | $49.3M | $51.8M | 26.1% | 13.7% | 81 | 尚无授权文本 |
| KWR QUAKER CHEMICAL CORP | 2026-06-30 | 3/3 | $532.55M | $26.84M | $12.22M | 35.5% | 7.6% | 80 | 尚无授权文本 |
| MOH MOLINA HEALTHCARE, INC. | 2026-06-30 | 3/3 | $10.87B | $60M | $731M | 13.2% | 1.3% | 118 | 尚无授权文本 |
| NSC NORFOLK SOUTHERN CORP | 2026-06-30 | 3/3 | $3.47B | $734M | $577M | — | 32.4% | 100 | 尚无授权文本 |
| NTRS NORTHERN TRUST CORP | 2026-06-30 | 3/3 | $1.35B | $792.2M | -$419.7M | — | — | 75 | 尚无授权文本 |
| NTRSO NORTHERN TRUST CORP | 2026-06-30 | 3/3 | $1.35B | $792.2M | -$419.7M | — | — | 75 | 尚无授权文本 |
| OHI OMEGA HEALTHCARE INVESTORS INC | 2026-06-30 | 3/3 | $13.99M | $362.82M | — | — | 2365.9% | 99 | 尚无授权文本 |
| OPK OPKO HEALTH, INC. | 2026-06-30 | 3/3 | $163.58M | -$8.42M | — | 48.9% | -4.3% | 98 | 尚无授权文本 |
| PTCT PTC THERAPEUTICS, INC. | 2026-06-30 | 3/3 | $360.52M | $83.5M | $66.68M | — | 41.3% | 107 | 尚无授权文本 |
| SHW SHERWIN WILLIAMS CO | 2026-06-30 | 3/3 | $6.79B | $843.6M | — | 49.2% | — | 103 | 尚无授权文本 |
| SMMT Summit Therapeutics Inc. | 2026-06-30 | 3/3 | — | -$215.7M | -$264.57M | — | — | 145 | 尚无授权文本 |
| SPHR Sphere Entertainment Co. | 2026-06-30 | 3/3 | $313.2M | -$38.33M | — | — | -19.6% | 119 | 尚无授权文本 |
| TDOC Teladoc Health, Inc. | 2026-06-30 | 3/3 | $606.93M | -$38.91M | $71.59M | — | -6.1% | 94 | 尚无授权文本 |
| THC TENET HEALTHCARE CORP | 2026-06-30 | 3/3 | $5.63B | $1.05B | $1.88B | — | 26.7% | 107 | 尚无授权文本 |
| THRM Gentherm Inc | 2026-06-30 | 3/3 | $416.17M | $4.42M | -$11.93M | 23.2% | 2.6% | 90 | 尚无授权文本 |
| VKTX Viking Therapeutics, Inc. | 2026-06-30 | 3/3 | $0 | -$128.02M | — | — | — | 70 | 尚无授权文本 |
| WFRD Weatherford International plc | 2026-06-30 | 3/3 | — | $39M | $215M | — | — | 99 | 尚无授权文本 |
| HSY HERSHEY CO | 2026-06-28 | 3/3 | $2.79B | $457.67M | $683.7M | 45.3% | 23.1% | 88 | 尚无授权文本 |
| LMT LOCKHEED MARTIN CORP | 2026-06-28 | 3/3 | $20.06B | $1.84B | — | 12.2% | 12.4% | 93 | 尚无授权文本 |
| DHR DANAHER CORP /DE/ | 2026-06-26 | 3/3 | $6.27B | $870M | $2.35B | 57.6% | 18.0% | 92 | 尚无授权文本 |
| HELE HELEN OF TROY LTD | 2026-05-31 | 3/3 | $402.12M | $35.76M | — | 46.0% | 15.0% | 89 | 尚无授权文本 |
| NRIX Nurix Therapeutics, Inc. | 2026-05-31 | 3/3 | $9.04M | -$89.54M | -$171.47M | — | -1041.7% | 102 | 尚无授权文本 |
| NTIC NORTHERN TECHNOLOGIES INTERNATIONAL CORP | 2026-05-31 | 3/3 | $24.22M | -$263,291 | -$1.81M | 33.6% | 2.1% | 63 | 尚无授权文本 |
| PAYX PAYCHEX INC | 2026-05-31 | 3/3 | $6.3B | $1.76B | $2.32B | 73.4% | 39.8% | 79 | 尚无授权文本 |
| CHWY Chewy, Inc. | 2026-05-03 | 3/3 | $3.36B | $94.8M | — | 30.1% | 3.8% | 85 | 尚无授权文本 |
| WOOF Petco Health & Wellness Company, Inc. | 2026-05-02 | 3/3 | $1.5B | -$15.15M | -$69.12M | 38.4% | 1.6% | 92 | 尚无授权文本 |
| BCTX BriaCell Therapeutics Corp. | 2026-04-30 | 3/3 | — | -$7.16M | -$22.82M | — | — | 133 | 尚无授权文本 |
| ENGN enGene Therapeutics Inc. | 2026-04-30 | 3/3 | — | -$30.23M | -$59.65M | — | — | 53 | 尚无授权文本 |
| HEI HEICO CORP | 2026-04-30 | 3/3 | $1.38B | $233.8M | $439.02M | 41.4% | 25.5% | 75 | 尚无授权文本 |
| HPE Hewlett Packard Enterprise Co | 2026-04-30 | 3/3 | $10.68B | $624M | — | — | 7.0% | 121 | 尚无授权文本 |
| HQY HEALTHEQUITY, INC. | 2026-04-30 | 3/3 | $354.64M | $69.42M | $97.16M | 72.3% | 29.0% | 109 | 尚无授权文本 |
| HSCS HeartSciences Inc. | 2026-04-30 | 3/3 | $4,319 | -$9.14M | -$7.43M | 59.1% | -194787.4% | 102 | 尚无授权文本 |
| RENT Rent the Runway, Inc. | 2026-04-30 | 3/3 | $12.2M | -$18.9M | — | -93.4% | -161.5% | 65 | 尚无授权文本 |
| TOL Toll Brothers, Inc. | 2026-04-30 | 3/3 | — | $260.59M | $98.39M | — | — | 77 | 尚无授权文本 |
| JACK JACK IN THE BOX INC | 2026-04-12 | 3/3 | $254.26M | $10.25M | — | — | 13.9% | 97 | 尚无授权文本 |
| AVAH Aveanna Healthcare Holdings, Inc. | 2026-04-04 | 3/3 | $647.92M | $41.65M | — | 31.7% | 10.7% | 92 | 尚无授权文本 |
| HLIO HELIOS TECHNOLOGIES, INC. | 2026-04-04 | 3/3 | $228.4M | $19.7M | $17.2M | 32.8% | 13.1% | 108 | 尚无授权文本 |
| USNA USANA HEALTH SCIENCES INC | 2026-04-04 | 3/3 | $250.22M | $7.52M | $7.11M | 76.2% | 5.5% | 69 | 尚无授权文本 |
| AARD Aardvark Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$21.59M | — | — | — | 26 | 尚无授权文本 |
| ABEO ABEONA THERAPEUTICS INC. | 2026-03-31 | 3/3 | $8.72M | -$17.08M | -$20.74M | 69.1% | -264.1% | 111 | 尚无授权文本 |
| ACH ACCENDRA HEALTH INC/VA/ | 2026-03-31 | 3/3 | $627.78M | -$6.47M | — | 44.3% | 2.7% | 118 | 尚无授权文本 |
| ACHC Acadia Healthcare Company, Inc. | 2026-03-31 | 3/3 | $828.8M | $4.11M | -$15.03M | — | — | 91 | 尚无授权文本 |
| ACHR Archer Aviation Inc. | 2026-03-31 | 3/3 | $1.6M | -$217.7M | -$181.7M | — | -15912.5% | 113 | 尚无授权文本 |
| ACRS Aclaris Therapeutics, Inc. | 2026-03-31 | 3/3 | $2M | -$19.82M | -$18.16M | 80.2% | -1111.8% | 97 | 尚无授权文本 |
| ACRV Acrivon Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$19.04M | -$20.55M | — | — | 57 | 尚无授权文本 |
| ACTU ACTUATE THERAPEUTICS, INC. | 2026-03-31 | 3/3 | — | -$5.63M | — | — | — | 27 | 尚无授权文本 |
| ADCT ADC Therapeutics SA | 2026-03-31 | 3/3 | $20.03M | -$32.97M | -$29.74M | — | -126.0% | 168 | 尚无授权文本 |
| ADM Archer-Daniels-Midland Co | 2026-03-31 | 3/3 | $6.14B | $298M | -$44M | 19.9% | — | 85 | 尚无授权文本 |
| AFJK Aimei Health Technology Co., Ltd. | 2026-03-31 | 3/3 | — | $45,440 | — | — | — | 44 | 尚无授权文本 |
| AFJKU Aimei Health Technology Co., Ltd. | 2026-03-31 | 3/3 | — | $45,440 | — | — | — | 44 | 尚无授权文本 |
| AGL agilon health, inc. | 2026-03-31 | 3/3 | $1.42B | $48.92M | $20.63M | — | 0.3% | 76 | 尚无授权文本 |
| AHCO AdaptHealth Corp. | 2026-03-31 | 3/3 | $819.8M | -$16.04M | -$27.49M | 13.6% | 0.7% | 106 | 尚无授权文本 |
| AHG Akso Health Group | 2026-03-31 | 3/3 | $13.83M | -$18.67M | -$12.79M | -0.1% | -149.7% | 48 | 尚无授权文本 |
| AHR American Healthcare REIT, Inc. | 2026-03-31 | 3/3 | $609.77M | $23.71M | — | 16.0% | 20.6% | 127 | 尚无授权文本 |
| AJG Arthur J. Gallagher & Co. | 2026-03-31 | 3/3 | $4.76B | $822M | — | — | — | 106 | 尚无授权文本 |
| AKBA Akebia Therapeutics, Inc. | 2026-03-31 | 3/3 | $53.54M | -$9.05M | -$21.27M | 77.0% | -8.8% | 128 | 尚无授权文本 |
| AKTX Akari Therapeutics Plc | 2026-03-31 | 3/3 | — | -$14.46M | — | — | — | 135 | 尚无授权文本 |
| ALDX Aldeyra Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$3.45M | — | — | — | 103 | 尚无授权文本 |
| ALGS Aligos Therapeutics, Inc. | 2026-03-31 | 3/3 | $2.83M | -$23.04M | — | — | -951.6% | 76 | 尚无授权文本 |
| ALLO Allogene Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$42.61M | -$12.92M | — | — | 88 | 尚无授权文本 |
| ALLR Allarity Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$2.75M | -$4.56M | — | — | 167 | 尚无授权文本 |
| AMN AMN HEALTHCARE SERVICES INC | 2026-03-31 | 3/3 | $1.38B | $62.17M | $555.21M | 26.8% | 8.5% | 86 | 尚无授权文本 |
| ANTX AN2 Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$10.03M | — | — | — | 56 | 尚无授权文本 |
| ANY Sphere 3D Corp. | 2026-03-31 | 3/3 | $1.92M | -$4.11M | -$3.72M | 16.3% | -215.6% | 168 | 尚无授权文本 |
| APGE Apogee Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$74.11M | — | — | — | 49 | 尚无授权文本 |
| APH AMPHENOL CORP /DE/ | 2026-03-31 | 3/3 | $7.62B | $933M | $829.9M | 36.7% | 24.0% | 97 | 尚无授权文本 |
| APRE Aprea Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$3.29M | — | — | — | 107 | 尚无授权文本 |
| APVO Aptevo Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$6.7M | — | — | — | 135 | 尚无授权文本 |
| AQST Aquestive Therapeutics, Inc. | 2026-03-31 | 3/3 | $14.45M | -$8.06M | -$14.86M | 76.0% | -29.1% | 163 | 尚无授权文本 |
| ARCT Arcturus Therapeutics Holdings Inc. | 2026-03-31 | 3/3 | $2.06M | -$26.96M | -$19.44M | — | -1403.7% | 98 | 尚无授权文本 |
| ARDT Ardent Health, Inc. | 2026-03-31 | 3/3 | $1.6B | $39.85M | — | — | — | 27 | 尚无授权文本 |
| ARQT Arcutis Biotherapeutics, Inc. | 2026-03-31 | 3/3 | $105.4M | -$11.3M | $2.24M | 90.7% | -8.6% | 91 | 尚无授权文本 |
| ARTV Artiva Biotherapeutics, Inc. | 2026-03-31 | 3/3 | — | -$23.52M | -$21.19M | — | — | 27 | 尚无授权文本 |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | 2026-03-31 | 3/3 | $73.74M | -$132.73M | $93.21M | — | -191.6% | 86 | 尚无授权文本 |
| ASTH Astrana Health, Inc. | 2026-03-31 | 3/3 | $965.1M | $14.44M | $64.06M | — | 3.0% | 138 | 尚无授权文本 |
| ATHR Aether Holdings, Inc. | 2026-03-31 | 3/3 | $336,041 | -$1.03M | -$3.1M | 80.7% | — | 16 | 尚无授权文本 |
| ATHS Athene Holding Ltd. | 2026-03-31 | 3/3 | $3.67B | -$1.94B | — | — | — | 165 | 尚无授权文本 |
| ATOS ATOSSA THERAPEUTICS, INC. | 2026-03-31 | 3/3 | — | -$9.59M | -$9.58M | — | — | 102 | 尚无授权文本 |
| ATRA Atara Biotherapeutics, Inc. | 2026-03-31 | 3/3 | $516,000 | -$4.15M | — | — | -652.9% | 109 | 尚无授权文本 |
| AUTL Autolus Therapeutics plc | 2026-03-31 | 3/3 | $26.22M | -$71.6M | -$68.01M | 6.3% | -227.0% | 90 | 尚无授权文本 |
| AVAT Avalanche Treasury Corp | 2026-03-31 | 2/3 | $0 | -$139,635 | — | — | — | 7 | 尚无授权文本 |
| AVTX Avalo Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$19.63M | — | — | — | 141 | 尚无授权文本 |
| AXSM Axsome Therapeutics, Inc. | 2026-03-31 | 3/3 | $191.2M | -$64.54M | -$20.82M | — | -33.1% | 147 | 尚无授权文本 |
| BBOT BridgeBio Oncology Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$42.11M | -$35.94M | — | — | 26 | 尚无授权文本 |
| BCAX Bicara Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$56.21M | -$37.57M | — | — | 25 | 尚无授权文本 |
| BCPC BALCHEM CORP | 2026-03-31 | 3/3 | $270.71M | $40.29M | — | 37.3% | 20.5% | 79 | 尚无授权文本 |
| BDTX Black Diamond Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$9.04M | — | — | — | 81 | 尚无授权文本 |
| BEAM Beam Therapeutics Inc. | 2026-03-31 | 3/3 | $31.74M | -$94.32M | -$130.75M | — | -337.8% | 88 | 尚无授权文本 |
| BEAT HeartBeam, Inc. | 2026-03-31 | 3/3 | — | -$4.7M | -$3.86M | — | — | 57 | 尚无授权文本 |
| BHRB Burke & Herbert Financial Services Corp. | 2026-03-31 | 3/3 | — | $27.35M | $24.63M | — | — | 57 | 尚无授权文本 |
| BOLT Bolt Biotherapeutics, Inc. | 2026-03-31 | 3/3 | $26,000 | -$7.24M | — | — | -29234.6% | 65 | 尚无授权文本 |
| BOTJ BANK OF THE JAMES FINANCIAL GROUP INC | 2026-03-31 | 3/3 | — | $2.77M | $4.36M | — | — | 76 | 尚无授权文本 |
| BOW Bowhead Specialty Holdings Inc. | 2026-03-31 | 3/3 | $155.69M | $16.01M | $64.17M | — | — | 26 | 尚无授权文本 |
| BRNS Barinthus Biotherapeutics plc. | 2026-03-31 | 3/3 | — | -$5.53M | -$3.37M | — | — | 74 | 尚无授权文本 |
| BRTX BioRestorative Therapies, Inc. | 2026-03-31 | 3/3 | $23,170 | -$2.15M | — | 68.1% | -14612.6% | 74 | 尚无授权文本 |
| BTAI BioXcel Therapeutics, Inc. | 2026-03-31 | 3/3 | $206,000 | -$12.69M | -$11.81M | -37.4% | -4962.6% | 142 | 尚无授权文本 |
| CADL Candel Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$8.86M | -$18.71M | — | — | 102 | 尚无授权文本 |
| CAKE CHEESECAKE FACTORY INC | 2026-03-31 | 3/3 | $978.83M | $49.55M | $53.35M | — | 5.6% | 70 | 尚无授权文本 |
| CAMP Camp4 Therapeutics Corp | 2026-03-31 | 3/3 | $1.29M | -$18.33M | -$10.98M | — | -1010.1% | 29 | 尚无授权文本 |
| CAPR CAPRICOR THERAPEUTICS, INC. | 2026-03-31 | 3/3 | — | -$33.94M | -$34.38M | — | — | 93 | 尚无授权文本 |
| CATX Perspective Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$26.19M | -$38.33M | — | — | 152 | 尚无授权文本 |
| CC Chemours Co | 2026-03-31 | 3/3 | $1.38B | -$29M | -$93M | 15.4% | — | 128 | 尚无授权文本 |
| CCCC C4 Therapeutics, Inc. | 2026-03-31 | 3/3 | $6.15M | -$25.13M | -$30.01M | — | -451.6% | 96 | 尚无授权文本 |
| CCII Cohen Circle Acquisition Corp. II | 2026-03-31 | 3/3 | — | $1.87M | — | — | — | 7 | 尚无授权文本 |
| CGEM Cullinan Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$49.66M | — | — | — | 83 | 尚无授权文本 |
| CGTX COGNITION THERAPEUTICS INC | 2026-03-31 | 3/3 | — | -$4.57M | — | — | — | 89 | 尚无授权文本 |
| CHCT Community Healthcare Trust Inc | 2026-03-31 | 3/3 | $31.52M | $2.55M | — | — | — | 79 | 尚无授权文本 |
| CHE CHEMED CORP | 2026-03-31 | 3/3 | $657.51M | $66.3M | $71.1M | 32.8% | 12.9% | 65 | 尚无授权文本 |
| CHEC Chenghe Acquisition III Co. | 2026-03-31 | 3/3 | — | $884,748 | — | — | — | 7 | 尚无授权文本 |
| CHGG CHEGG, INC | 2026-03-31 | 3/3 | $63.26M | $228,000 | $3.06M | 59.9% | -1.6% | 101 | 尚无授权文本 |
| CHMG CHEMUNG FINANCIAL CORP | 2026-03-31 | 3/3 | — | $9.2M | $8.91M | — | — | 127 | 尚无授权文本 |
| CHMI Cherry Hill Mortgage Investment Corp | 2026-03-31 | 3/3 | — | $429,000 | — | — | — | 73 | 尚无授权文本 |
| CHRS Coherus Oncology, Inc. | 2026-03-31 | 3/3 | — | -$38.33M | — | — | — | 116 | 尚无授权文本 |
| CIFR Cipher Digital Inc. | 2026-03-31 | 3/3 | $34.84M | -$114.32M | -$462.46M | 49.2% | -328.9% | 107 | 尚无授权文本 |
| CLDI Calidi Biotherapeutics, Inc. | 2026-03-31 | 3/3 | — | -$4.11M | — | — | — | 119 | 尚无授权文本 |
| CLDX Celldex Therapeutics, Inc. | 2026-03-31 | 3/3 | $15,000 | -$78.69M | -$67.23M | — | -562900.0% | 71 | 尚无授权文本 |
| CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | 2026-03-31 | 3/3 | $749.19M | $27.33M | $107.04M | — | 3.6% | 121 | 尚无授权文本 |
| CMPX Compass Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$18.32M | -$17.35M | — | — | 77 | 尚无授权文本 |
| CNS COHEN & STEERS, INC. | 2026-03-31 | 3/3 | — | $42.37M | — | — | — | 71 | 尚无授权文本 |
| CNTX Context Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$8.68M | -$11.47M | — | — | 70 | 尚无授权文本 |
| COAG Hemab Therapeutics Holdings, Inc. | 2026-03-31 | 3/3 | — | -$22.69M | -$21.7M | — | — | 4 | 尚无授权文本 |
| COHN Cohen & Co Inc. | 2026-03-31 | 3/3 | $57.9M | $1.49M | -$31.54M | — | 8.9% | 98 | 尚无授权文本 |
| COHR COHERENT CORP. | 2026-03-31 | 3/3 | $1.81B | $191.4M | -$537.17M | 37.7% | — | 125 | 尚无授权文本 |
| COSM Cosmos Health Inc. | 2026-03-31 | 3/3 | $17.93M | -$2.81M | -$1.08M | 7.7% | -12.2% | 102 | 尚无授权文本 |
| COYA Coya Therapeutics, Inc. | 2026-03-31 | 3/3 | $251,147 | -$7.21M | — | — | -3042.1% | 64 | 尚无授权文本 |
| CPK CHESAPEAKE UTILITIES CORP | 2026-03-31 | 3/3 | $353.1M | $59.3M | -$23.9M | — | 28.2% | 113 | 尚无授权文本 |
| CQP Cheniere Energy Partners, L.P. | 2026-03-31 | 3/3 | $3.6B | $186M | $879M | — | 10.0% | 114 | 尚无授权文本 |
| CRSP CRISPR Therapeutics AG | 2026-03-31 | 3/3 | $1.46M | -$122.93M | -$109.4M | — | -8933.3% | 94 | 尚无授权文本 |
| CTMX CytomX Therapeutics, Inc. | 2026-03-31 | 3/3 | $10.26M | -$18.25M | -$25.55M | — | -191.8% | 87 | 尚无授权文本 |
| CTNT CHEETAH NET SUPPLY CHAIN SERVICE INC. | 2026-03-31 | 3/3 | $92,700 | -$616,265 | — | 21.4% | -824.5% | 58 | 尚无授权文本 |
| CUB Lionheart Holdings | 2026-03-31 | 3/3 | — | $1.93M | — | — | — | 17 | 尚无授权文本 |
| CVKD Cadrenal Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$2.5M | — | — | — | 71 | 尚无授权文本 |
| CVS CVS HEALTH Corp | 2026-03-31 | 3/3 | $100.43B | $2.94B | $3.4B | 44.8% | 4.7% | 128 | 尚无授权文本 |
| CVX CHEVRON CORP | 2026-03-31 | 3/3 | $47.56B | $2.21B | — | 40.6% | — | 103 | 尚无授权文本 |
| CYCN Cyclerion Therapeutics, Inc. | 2026-03-31 | 3/3 | $0 | -$3.18M | -$1.24M | — | — | 78 | 尚无授权文本 |
| CYPH CYPHERPUNK TECHNOLOGIES INC. | 2026-03-31 | 3/3 | — | -$77.17M | — | — | — | 101 | 尚无授权文本 |
| CZNC CITIZENS & NORTHERN CORP | 2026-03-31 | 3/3 | — | $273,000 | $8.47M | — | — | 75 | 尚无授权文本 |
| DCOY Decoy Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$2.22M | — | — | — | 114 | 尚无授权文本 |
| DFTX Definium Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$77.1M | — | — | — | 138 | 尚无授权文本 |
| DH Definitive Healthcare Corp. | 2026-03-31 | 3/3 | $55.93M | -$138.62M | $8.36M | 74.5% | -359.9% | 65 | 尚无授权文本 |
| DHC DIVERSIFIED HEALTHCARE TRUST | 2026-03-31 | 3/3 | $366.47M | -$43.28M | — | — | — | 96 | 尚无授权文本 |
| DHCNI DIVERSIFIED HEALTHCARE TRUST | 2026-03-31 | 3/3 | $366.47M | -$43.28M | — | — | — | 96 | 尚无授权文本 |
| DHCNL DIVERSIFIED HEALTHCARE TRUST | 2026-03-31 | 3/3 | $366.47M | -$43.28M | — | — | — | 96 | 尚无授权文本 |
| DMAC DiaMedica Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$10.04M | -$9.09M | — | — | 84 | 尚无授权文本 |
| DMLP DORCHESTER MINERALS, L.P. | 2026-03-31 | 3/3 | — | $29.14M | — | — | — | 111 | 尚无授权文本 |
| DMRA Damora Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$27.78M | — | — | — | 63 | 尚无授权文本 |
| DNLI Denali Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$128.45M | -$133.67M | — | — | 97 | 尚无授权文本 |
| DNTH Dianthus Therapeutics, Inc. /DE/ | 2026-03-31 | 3/3 | — | -$40.83M | — | — | — | 89 | 尚无授权文本 |
| DOC HEALTHPEAK PROPERTIES, INC. | 2026-03-31 | 3/3 | $200.35M | $193.63M | — | — | — | 112 | 尚无授权文本 |
| DRIO DarioHealth Corp. | 2026-03-31 | 3/3 | — | -$8.25M | -$6.06M | — | — | 90 | 尚无授权文本 |
| DRMA Dermata Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$1.85M | — | — | — | 94 | 尚无授权文本 |
| DSGN Design Therapeutics, Inc. | 2026-03-31 | 3/3 | $0 | -$17.64M | -$16.43M | — | — | 58 | 尚无授权文本 |
| DWTX Dogwood Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$4.99M | — | — | — | 93 | 尚无授权文本 |
| EHC Encompass Health Corp | 2026-03-31 | 3/3 | $1.59B | $194.5M | — | — | — | 101 | 尚无授权文本 |
| EHTH eHealth, Inc. | 2026-03-31 | 3/3 | $88.02M | -$4.71M | $35.61M | 41.7% | -3.3% | 99 | 尚无授权文本 |
| EIKN Eikon Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$82.96M | -$90.06M | — | — | 7 | 尚无授权文本 |
| ELAN Elanco Animal Health Inc | 2026-03-31 | 3/3 | $1.37B | $57M | -$38M | 57.3% | — | 103 | 尚无授权文本 |
| ELTX Elicio Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$11.82M | — | — | — | 99 | 尚无授权文本 |
| ELVN Enliven Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$23.63M | — | — | — | 75 | 尚无授权文本 |
| EMN EASTMAN CHEMICAL CO | 2026-03-31 | 3/3 | $2.18B | $107M | -$240M | 19.8% | — | 84 | 尚无授权文本 |
| ERNA Ernexa Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$5.51M | -$2.27M | — | — | 135 | 尚无授权文本 |
| EVH Evolent Health, Inc. | 2026-03-31 | 3/3 | $496.25M | -$26.63M | — | 16.9% | -2.1% | 105 | 尚无授权文本 |
| EWTX Edgewise Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$49.01M | -$42.8M | — | — | 69 | 尚无授权文本 |
| FATE FATE THERAPEUTICS INC | 2026-03-31 | 3/3 | $1.3M | -$31.21M | -$31.06M | — | -2540.4% | 81 | 尚无授权文本 |
| FDMT 4D Molecular Therapeutics, Inc. | 2026-03-31 | 3/3 | $3.05M | -$68.76M | — | — | -2416.1% | 86 | 尚无授权文本 |
| FHI FEDERATED HERMES, INC. | 2026-03-31 | 3/3 | $478.96M | $96.38M | $24M | — | 26.4% | 64 | 尚无授权文本 |
| FHTX Foghorn Therapeutics Inc. | 2026-03-31 | 3/3 | $3.27M | -$19.88M | -$25.27M | — | -660.3% | 110 | 尚无授权文本 |
| FLNA FILANA THERAPEUTICS, INC. | 2026-03-31 | 3/3 | — | -$10.33M | — | — | — | 117 | 尚无授权文本 |
| FNRN FIRST NORTHERN COMMUNITY BANCORP | 2026-03-31 | 3/3 | — | $5.91M | $3.76M | — | — | 73 | 尚无授权文本 |
| GALT GALECTIN THERAPEUTICS INC | 2026-03-31 | 3/3 | — | -$5.05M | — | — | — | 93 | 尚无授权文本 |
| GANX Gain Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$5.61M | — | — | — | 84 | 尚无授权文本 |
| GEHC GE HealthCare Technologies Inc. | 2026-03-31 | 3/3 | $5.13B | $389M | — | 38.5% | 10.0% | 66 | 尚无授权文本 |
| GLUE Monte Rosa Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$44.5M | -$39.24M | — | — | 69 | 尚无授权文本 |
| GPCR Structure Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$75.97M | $14.05M | — | — | 48 | 尚无授权文本 |
| GRCE Grace Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$7.79M | — | — | — | 110 | 尚无授权文本 |
| GSBC GREAT SOUTHERN BANCORP, INC. | 2026-03-31 | 3/3 | — | $17.48M | $19.88M | — | — | 111 | 尚无授权文本 |
| GSHR Gesher Acquisition Corp. II | 2026-03-31 | 3/3 | — | $891,601 | — | — | — | 10 | 尚无授权文本 |
| GUTS FRACTYL HEALTH, INC. | 2026-03-31 | 3/3 | — | $9.22M | — | — | — | 50 | 尚无授权文本 |
| GYRE GYRE THERAPEUTICS, INC. | 2026-03-31 | 3/3 | $22.52M | -$9.86M | $3M | 94.6% | -41.5% | 126 | 尚无授权文本 |
| HALO HALOZYME THERAPEUTICS, INC. | 2026-03-31 | 3/3 | $376.71M | $150.05M | $176.34M | 79.0% | 49.0% | 99 | 尚无授权文本 |